Literature DB >> 3209111

Rectal hyperplasia after jejunoileal bypass for morbid obesity.

G V Appleton1, E E Wheeler, R Al-Mufti, D N Challacombe, R C Williamson.   

Abstract

Jejunoileal bypass (JIB) has been widely used to treat patients with morbid obesity for the past 20 years. In rats JIB causes adaptive colonic hyperplasia and enhances colorectal neoplasia. In this study crypt cell production rate (CCPR) was measured stathmokinetically in cultured rectal biopsies from nine patients with JIB and seven controls without intestinal operations or disease. Crypt cell production rate in the group with JIB was more than double that of controls (12.80 (2.67) v 6.23 (1.49) cells/crypt/h: p less than 0.001). There were no significant differences in crypt morphometry and histological examination of rectal biopsies was normal. Patients with JIB have a marked and persistent increase in cell proliferation in the large intestine and may be at increased risk of developing colonic cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3209111      PMCID: PMC1433847          DOI: 10.1136/gut.29.11.1544

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Surgical treatment of obesity.

Authors:  J H Payne; L T DeWind
Journal:  Am J Surg       Date:  1969-08       Impact factor: 2.565

2.  Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse.

Authors:  A Allan; J B Bristol; R C Williamson
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

Review 3.  The metaphase arrest technique. A critical review.

Authors:  N A Wright; D R Appleton
Journal:  Cell Tissue Kinet       Date:  1980-11

4.  Technique for microdissection and measurement in biopsies of human small intestine.

Authors:  A Ferguson; A Sutherland; T T MacDonald; F Allan
Journal:  J Clin Pathol       Date:  1977-11       Impact factor: 3.411

5.  A 13-year review of jejunoileal bypass.

Authors:  R J McFarland; J C Gazet; T R Pilkington
Journal:  Br J Surg       Date:  1985-02       Impact factor: 6.939

6.  Jejunoileal bypass for the treatment of massive obesity. Prevalence, morbidity, and short- and long-term consequences.

Authors:  F L Iber; M Copper
Journal:  Am J Clin Nutr       Date:  1977-01       Impact factor: 7.045

7.  Intestinal adaptation after jejunoileal bypass in man.

Authors:  R E Barry; J Barisch; G A Bray; M A Sperling; R J Morin; J Benfield
Journal:  Am J Clin Nutr       Date:  1977-01       Impact factor: 7.045

8.  Enteroglucagon and experimental intestinal carcinogenesis in the rat.

Authors:  A P Savage; J L Matthews; M A Ghatei; T Cooke; S R Bloom
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

9.  Enhanced colonic carcinogenesis with azoxymethane in rats after pancreaticobiliary diversion to mid small bowel.

Authors:  R C Williamson; F L Bauer; J S Ross; J B Watkins; R A Malt
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

10.  Adaptation and carcinogenesis in defunctioned rat colon: divergent effects of faeces and bile acids.

Authors:  J B Rainey; P W Davies; J B Bristol; R C Williamson
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

View more
  8 in total

Review 1.  Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.

Authors:  Cornelia M Ulrich; Caroline Himbert; Andreana N Holowatyj; Stephen D Hursting
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-11       Impact factor: 46.802

2.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

3.  Validation of organ culture in colonic adaptation to surgical manipulation.

Authors:  G V Appleton; E E Wheeler; D N Challacombe; R C Williamson
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis.

Authors:  M G Thomas; K P Nugent; A Forbes; R C Williamson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

5.  Divergent effects of epidermal growth factor and calcipotriol on human rectal cell proliferation.

Authors:  M G Thomas; G R Brown; M R Alison; R C Williamson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

6.  Colon adenocarcinoma after jejunoileal bypass for morbid obesity.

Authors:  Lee Morris; Ilimbek Beketaev; Roberto Barrios; Patrick Reardon
Journal:  J Surg Case Rep       Date:  2017-11-16

7.  COULD THE INTESTINAL EPITHELIAL ALTERATIONS PROMOTED BY ROUX-EN-Y GASTRIC BYPASS EXPLAIN HIGHER TENDENCY FOR COLONIC DISEASES IN BARIATRIC PATIENTS?

Authors:  Eduardo Wendler; Osvaldo Malafaia; Bruno Luiz Ariede; Jurandir Marcondes Ribas-Filho; Nicolau Gregori Czeczko; Paulo Afonso Nunes Nassif
Journal:  Arq Bras Cir Dig       Date:  2021-03-22

8.  Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery.

Authors:  Sorena Afshar; Fiona Malcomson; Seamus B Kelly; Keith Seymour; Sean Woodcock; John C Mathers
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.